S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
The Latest: Oregon governor blames feds for vaccine delay
The Latest: Spain confident of vaccine program despite delay
Nestlé recalls 762,000 pounds of pepperoni Hot Pockets
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
The Latest: Oregon governor blames feds for vaccine delay
The Latest: Spain confident of vaccine program despite delay
Nestlé recalls 762,000 pounds of pepperoni Hot Pockets
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
The Latest: Oregon governor blames feds for vaccine delay
The Latest: Spain confident of vaccine program despite delay
Nestlé recalls 762,000 pounds of pepperoni Hot Pockets
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
3 Recession-Proof Dividend Stocks to Buy Now
MarketBeat Week in Review 1/11 - 1/15
Ralph Lauren drops Justin Thomas after gay slur heard on TV
The Latest: Mexico hits another record for COVID-19 cases
pixel
The Latest: Oregon governor blames feds for vaccine delay
The Latest: Spain confident of vaccine program despite delay
Nestlé recalls 762,000 pounds of pepperoni Hot Pockets
pixel
Log in
NASDAQ:NTLA

Intellia Therapeutics Earnings Date, Estimates & History

$81.89
-1.41 (-1.69 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$81.59
Now: $81.89▼
$92.00
50-Day Range
$38.10
MA: $57.05▼
$83.30
52-Week Range
$9.18
Now: $81.89▼
$92.00
Volume2.62 million shs
Average Volume1.82 million shs
Market Capitalization$4.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.09

Earnings

Intellia Therapeutics (NASDAQ:NTLA) Earnings Information

Intellia Therapeutics last released its quarterly earnings results on November 5th, 2020. The reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($0.54) by $0.07. The firm had revenue of $22.22 million for the quarter, compared to analyst estimates of $14.95 million. Its revenue for the quarter was up 109.2% on a year-over-year basis. Intellia Therapeutics has generated ($2.11) earnings per share over the last year. Intellia Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 25th, 2021 based off prior year's report dates.

Intellia Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Intellia Therapeutics (NASDAQ:NTLA) Earnings Estimates

2021 EPS Consensus Estimate: ($2.88)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20212($0.74)($0.69)($0.72)
Q2 20212($0.78)($0.68)($0.73)
Q3 20212($0.71)($0.70)($0.71)
Q4 20212($0.73)($0.73)($0.73)

Intellia Therapeutics (NASDAQ NTLA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/25/2021
(Estimated)		       
11/5/2020Q3($0.54)($0.47)($0.47)$14.95 million$22.22 millionTranscript
8/6/2020Q2($0.69)($0.61)($0.61)$9.52 million$16.26 millionTranscript
5/7/2020Q1($0.39)($0.63)($0.63)$21.98 million$12.92 millionTranscript
2/27/2020Q4 2019($0.56)($0.57)($0.57)$9.58 million$10.94 millionTranscript
10/31/2019Q3 2019($0.61)($0.49)($0.49)$9.17 million$10.60 millionTranscript
8/1/2019Q2 2019($0.61)($0.56)($0.56)$7.15 million$11.10 millionListen
5/2/2019Q1 2019($0.53)($0.49)($0.49)$9.43 million$10.43 millionN/A
2/27/2019Q4 2018($0.55)($0.43)($0.43)$9.92 million$7.90 millionN/A
10/31/20189/30/2018($0.48)($0.53)($0.53)$11.58 million$7.41 millionN/A
8/1/2018Q2 2018($0.55)($0.52)($0.52)$6.39 million$7.68 millionN/A
5/1/2018Q1 2018($0.5770)($0.51)($0.51)$6.14 million$7.47 millionN/A
3/14/2018Q4 2017($0.45)($0.61)($0.61)$8.84 million$6.70 millionN/A
10/31/2017Q3 2017($0.4960)($0.44)($0.44)$5.83 million$7.30 millionN/A
8/3/2017Q2 2017($0.4150)($0.45)($0.45)$5.83 million$5.90 millionN/A
5/2/2017Q1 2017($0.34)($0.3640)($0.36)$5.30 million$6.22 millionN/A
3/14/2017Q4 2016($0.21)($0.3060)($0.31)$5.63 million$5.63 millionN/A
11/1/2016Q3 2016($0.22)($0.22)($0.22)$4.55 million$4.90 millionN/A
8/4/2016Q2 2016($0.10)($0.36)($0.36)$6.34 million$4.21 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/16/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.